Community Health Centers’ Big Profits Raise Questions About Federal Oversight

Nonprofit federally funded health centers are a linchpin in the nation’s health care safety net because they treat the medically underserved. The average profit margin is 5%, but some have recorded margins of 20% or more in three of the past four years.

KHN’s ‘What the Health?’: A Big Week for Biden

Congress is leaving for its annual summer break having accomplished far more than many expected, including, barring unforeseen snags, a bill to address the cost of prescription drugs for Medicare beneficiaries and extend the enhanced subsidies for insurance premiums under the Affordable Care Act. Meanwhile, the abortion issue continues to roil the nation as Indiana becomes the first state to ban the procedure in almost all cases since the Supreme Court overruled the constitutional right to abortion in June. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.

They Call It ‘Tranq’ — And It’s Making Street Drugs Even More Dangerous

Xylazine, an animal tranquilizer, has made it into the illegal drug supply of opioids and cocaine. It is changing the way outreach workers treat overdoses and may be responsible for grisly injuries and infections among people who unknowingly inject it.

Tribe Embraces Recreational Marijuana Sales on Reservation Where Alcohol Is Banned

The Pine Ridge Indian Reservation in South Dakota allows people to buy and use recreational marijuana but not alcohol. Some tribal citizens say cannabis is safer than alcohol, meth, and opioids — which have wreaked havoc on the state’s Indigenous communities.

KHN’s ‘What the Health?’: Kansas Makes a Statement

In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas’ primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Bram Sable-Smith, who wrote the latest KHN-NPR “Bill of the Month” installment about a very expensive ambulance trip.

A California Man’s ‘Painful and Terrifying’ Road to a Monkeypox Diagnosis

A Bay Area man described himself as “delirious” from the pain of a quickly spreading rash, but it took six telehealth appointments, one urgent care visit, and two emergency room trips before he was finally diagnosed and treated for monkeypox.

Music Festivals Embrace Overdose Reversal Drugs, but Fentanyl Testing Kits Remain Taboo

Music festival promoters are allowing distribution of overdose reversal medication as fentanyl deaths continue to surge. But nonprofits and volunteers are often left to do the work, and more controversial forms of harm reduction aren’t openly allowed.

The Time Has Come for DIY Mandates on Covid

Yes, lots of us suffer from pandemic fatigue and have been getting sloppy about precautions in recent months. But with covid an ongoing menace — and governments reluctant to return to sweeping mandates — it’s time for all of us to step up our game.

KHN’s ‘What the Health?’: Manchin Makes a Deal

In a rare surprise for official Washington, Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D-W.Va.) announced a deal to expand the planned health bill in the Senate to include provisions raising taxes and addressing climate change. The measure would include a third year of expanded subsidies for the Affordable Care Act, but not health care coverage for people left out of Medicaid in states that failed to expand the program. Meanwhile, the ACA goes back to court, and the Biden administration restores anti-discrimination protections for LGBTQ+ people that were rolled back by the Trump administration. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Céline Gounder of KHN about the latest on the monkeypox outbreak.

Lo que debes saber sobre Paxlovid para tratar covid, en especial, ¿debes tomarlo?

Desde que Paxlovid comenzó a estar disponible hace siete meses, ha eclipsado otras terapias disponibles para prevenir los síntomas graves de covid en pacientes de alto riesgo. Algunos médicos se apresuran a recetarlo, pero como ocurre con tanto sobre la pandemia de covid, hay controversia.

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.

To Stem the Spread of Monkeypox, Health Departments Tap Into Networks of Those Most at Risk

Although the disease is currently spreading almost exclusively among men who have sex with men, some cases are turning up in other populations — and that number is likely to grow if public health officials don’t effectively nip the outbreak in the bud.